Novo Nordisk | NVO - Текущие обязательства





Текущие обязательства Изменить Дата
ANI Pharmaceuticals USD 328.72M 45.06M 2026-09
Aurora Cannabis CAD 73.43M 6.5M 2026-06
Bausch Health Companies USD 4.75B 205M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Canopy Growth CAD 166.75M 8.31M 2026-06
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Drreddys Laboratories INR 154.49B 13.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Merck USD 28.8B 1.07B 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 32.52B 777M 2026-09
Novo Nordisk DKK 239.08B 13.92B 2026-06
Novo Nordisk DKK 36.54B 188.62B 2026-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Phibro Animal Health USD 295.79M 20.68M 2026-09
Prestige Brands USD 168.5M 14.7M 2026-09
Sanofi EUR 29.77B 2.16B 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
Zoetis USD 2.68B 621M 2026-09